The angiotensin II/angiotensin II receptor system correlates with nodal spread in intestinal type gastric cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 16, Issue 6, 2007, Pages 1206-1212

  Röcken, Christoph ^a,b   Röhl, Friedrich Wilhelm ^b   Diebler, Eva ^b   Lendeckel, Uwe ^b   Pross, Matthias ^b   Carl McGrath, Stacy ^a   Ebert, Matthias P A ^c  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; ARTICLE; BIOLOGY; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA POLYMORPHISM; EPITHELIUM CELL; FEMALE; GENE DELETION; GENE FREQUENCY; GENE INSERTION SEQUENCE; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HORMONE RELEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PATHOLOGY; PREVALENCE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR; STOMACH CANCER; SURVIVAL TIME;

ADENOCARCINOMA; AGED; ANGIOTENSIN II; FEMALE; GENE EXPRESSION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; KAPLAN-MEIERS ESTIMATE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMERASE CHAIN REACTION; RECEPTORS, ANGIOTENSIN; STOMACH NEOPLASMS;

EID: 34250810884     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-05-0934     Document Type: Article

References (31)

1. Hohenberger P, Gretschel S. Gastric cancer. Lancet 2003;362:305-15.
2. Dicken BJ, Saunders LD, Jhangri GS, et al. Gastric cancer: establishing predictors of biologic behavior with use of population-based data. Ann Surg Oncol 2004;11:629-35.
3. Yokota T, Ishiyama S, Saito T, et al. Lymph node metastasis as a significant prognostic factor in gastric cancer: a multiple logistic regression analysis. Scand J Gastroenterol 2004;39:380-4.
4. Carl-McGrath S, Lendeckel U, Ebert M, et al. The ectopeptidases CD10, CD13, CD26, and CD143 are upregulated in gastric cancer. Int J Oncol 2004;25:1223-32.
5. Röcken C, Lendeckel U, Dierkes J, et al. The number of lymph node metastases in gastric cancer correlates with the angiotensin I-converting enzyme gene insertion/deletion polymorphism. Clin Cancer Res 2005;11:2526-30.
6. Escobar E, Rodriguez-Reyna TS, Arrieta O, et al. Angiotensin II, cell proliferation and angiogenesis regulator: biologic and therapeutic implications in cancer. Curr Vasc Pharmacol 2004;2:385-99.
7. Deshayes F, Nahmias C. Angiotensin receptors: a new role in cancer? Trends Endocrinol Metab 2005;16:293-9.
8. Lauren T. The two histologic main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Pathol Microbiol Scand 1965;64:31-49.
9. Yoshida H, Mitarai T, Kawamura T, et al. Role of the deletion of polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy. J Clin Invest 1995;96:2162-9.
10. Fleiss JL. The design and analysis of clinical experiments. New York: John Wiley & Sons; 1986. p. 13-4.
11. Everitt BS. Encyclopaedic companion to medical statistics. London: Hodder Arnold; 2005.
12. Collett D. Modelling survival data in medical research. London, New York: Chapman & Hall/CRC; 1999.
13. Cox DR, Oakes D. Analysis of survival data. London, New York: Chapman and Hall; 1985.
14. Bauvois B. Transmembrane proteases in cell growth and invasion: new contributors to angiogenesis? Oncogene 2004;23:317-29.
15. Batra VK, Gopalakrishnan V, McNeill JR, et al. Angiotensin II elevates cytosolic free calcium in human lung adenocarcinoma cells via activation of AT1 receptors. Cancer Lett 1994;76:19-24.
16. Egami K, Murohara T, Shimada T, et al. Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth. J Clin Invest 2003;112:67-75.
17. Fujita M, Hayashi I, Yamashina S, et al. Blockade of angiotensin AT1a receptor signaling reduces tumor growth, angiogenesis, and metastasis. Biochem Biophys Res Commun 2002;294:441-7.
18. Goldfarb DA, Diz DI, Tubbs RR, et al. Angiotensin II receptor subtypes in the human renal cortex and renal cell carcinoma. J Urol 1994;151:208-13.
19. Inwang ER, Puddefoot JR, Brown CL, et al. Angiotensin II type 1 receptor expression in human breast tissues. Br J Cancer 1997;75:1279-83.
20. Marsigliante S, Resta L, Muscella A, et al. AT1 angiotensin II receptor subtype in the human larynx and squamous laryngeal carcinoma. Cancer Lett 1996;110:19-27.
21. Tahmasebi M, Puddefoot JR, Inwang ER, et al. Transcription of the prorenin gene in normal and diseased breast. Eur J Cancer 1998;34:1777-82.
22. Volpert OV, Ward WF, Lingen MW, et al. Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats. J Clin Invest 1996;98:671-9.
23. Yoshiji H, Yoshii J, Ikenaka Y, et al. Suppression of the renin-angiotensin system attenuates vascular endothelial growth factor-mediated tumor development and angiogenesis in murine hepatocellular carcinoma cells. Int J Oncol 2002;20:1227-31.
24. Lever AF, Hole DJ, Gillis CR, et al. Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer? Lancet 1998;352:179-84.
25. Yoshiji H, Kuriyama S, Kawata M, et al. The angiotensin-I-converting enzyme inhibitor perindopril suppresses tumor growth and angiogenesis: possible role of the vascular endothelial growth factor. Clin Cancer Res 2001;7:1073-8.
26. Reddy MK, Baskaran K, Molteni A. Inhibitors of angiotensin-converting enzyme modulate mitosis and gene expression in pancreatic cancer cells. Proc Soc Exp Biol Med 1995;210:221-6.
27. Yasumaru M, Tsuji S, Tsujii M, et al. Inhibition of angiotensin II activity enhanced the antitumor effect of cyclooxygenase-2 inhibitors via insulin-like growth factor I receptor pathway. Cancer Res 2003;63:6726-34.
28. Suzuki Y, Ruiz-Ortega M, Lorenzo O, et al. Inflammation and angiotens in II. Int J Biochem Cell Biol 2003;35:881-900.
29. Smith GR, Missailidis S. Cancer, inflammation and the AT1 and AT2 receptors. J Inflamm (Lond) 2004;1:3.
30. Ebert MP, Lendeckel U, Westphal S, et al. The angiotensin I-converting enzyme gene insertion/deletion polymorphism is linked to early gastric cancer. Cancer Epidemiol Biomarkers Prev 2005;14:2987-9.
31. Abali H, Gullu IH, Engin H, et al. Old antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotens in II type 1 receptor antagonists. Med Hypotheses 2002;59:344-8.